Mediclinic surges as Remgro proposes healthier offer
Remgro and consortium partner MSC have increased their offer to 504p per share for SA’s most valuable hospital group
07 July 2022 - 14:05
UPDATED 07 July 2022 - 20:21
It was fourth time lucky for Remgro, which has gained support from Mediclinic for its new, higher offer to buy out the private hospital operator after being rejected three times.
Mediclinic shares logged their best gain since mid-October on Thursday after the group said it was willing to consider an improved proposal from a consortium including big shareholder Remgro that values it at £3.7bn (R74bn)...
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Commenting is subject to our house rules.
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now